Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. Toronto Stock Exchange
  5. ProMIS Neurosciences, Inc.
  6. News
  7. Summary
    PMN   CA74346M1095

PROMIS NEUROSCIENCES, INC.

(PMN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

ProMIS Neurosciences : Files Final Base Shelf Prospectus

07/08/2021 | 08:23am EDT


ę MT Newswires 2021
All news about PROMIS NEUROSCIENCES, INC.
09/16PROMIS NEUROSCIENCES : to Present at the Second Annual Undruggable Leaders Forum
AQ
09/15PROMIS NEUROSCIENCES : to Present at the Second Annual Undruggable Leaders Forum, Septembe..
AQ
09/15PROMIS NEUROSCIENCES : to Present at the Second Annual Undruggable Leaders Forum September..
PU
09/13PROMIS NEUROSCIENCES : to Participate in H.C. Wainwright & Co. 23rd Annual Investment Conf..
PU
09/01ProMIS Neurosciences Appoints "Accomplished" Biotechnology Executive, Josh Mandel-Brehm..
MT
09/01ProMIS Neurosciences, Inc. Appoints Josh Mandel-Brehm to Its Board of Directors
CI
09/01PROMIS NEUROSCIENCES : appoints accomplished biotechnology executive, Josh Mandel-Brehm, t..
PU
08/25PROMIS NEUROSCIENCES : Completes Public Unit Offering for Gross Proceeds of US$20.1 Millio..
MT
08/25ProMIS Neurosciences Closes Upsized US$20,125,000 Public Offering
GL
08/25ProMIS Neurosciences, Inc. announced a financing transaction
CI
More news
Financials
Sales 2020 0,00 M 0,00 M 0,00 M
Net income 2020 -5,66 M -4,47 M -4,47 M
Net cash 2020 1,07 M 0,85 M 0,85 M
P/E ratio 2020 -3,96x
Yield 2020 -
Capitalization 79,9 M 62,9 M 63,1 M
EV / Sales 2019 37 534x
EV / Sales 2020 15 614x
Nbr of Employees -
Free-Float 95,1%
Chart PROMIS NEUROSCIENCES, INC.
Duration : Period :
ProMIS Neurosciences, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PROMIS NEUROSCIENCES, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Managers and Directors
Elliot Goldstein President, Chief Executive Officer & Director
Daniel E. Geffken Chief Financial Officer
Eugene Williams Executive Chairman
Neil R. Cashman Director & Chief Scientific Officer
William W. Wyman Independent Director
Sector and Competitors
1st jan.Capi. (M$)
PROMIS NEUROSCIENCES, INC.85.00%63
GILEAD SCIENCES, INC.22.19%89 259
BIONTECH SE309.08%80 542
WUXI APPTEC CO., LTD.34.39%68 685
REGENERON PHARMACEUTICALS32.25%66 425
VERTEX PHARMACEUTICALS-22.31%47 634